The changing face of rheumatoid arthritis: sustained remission for all?
Identifieur interne : 001662 ( Main/Exploration ); précédent : 001661; suivant : 001663The changing face of rheumatoid arthritis: sustained remission for all?
Auteurs : John D. Isaacs [Royaume-Uni]Source :
- Nature Reviews Immunology [ 1474-1733 ] ; 2010-08.
Abstract
Earlier diagnosis and treatment, plus biological therapies, have transformed the outlook for many patients with rheumatoid arthritis. In the future, new biomarkers for diagnosis, prognosis and therapeutic response will further improve outcomes. Additionally, preclinical diagnosis and tolerogenic therapies could provide sustained remission for some individuals, although ethical and societal challenges must also be addressed before rheumatoid arthritis becomes 'yesterday's disease'.
Url:
DOI: 10.1038/nri2804
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001D11
- to stream Istex, to step Curation: 001D11
- to stream Istex, to step Checkpoint: 000607
- to stream Main, to step Merge: 001665
- to stream Main, to step Curation: 001662
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The changing face of rheumatoid arthritis: sustained remission for all?</title><author><name sortKey="Isaacs, John D" sort="Isaacs, John D" uniqKey="Isaacs J" first="John D." last="Isaacs">John D. Isaacs</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D6B77F81C014C52AFF52CA13D39A16E749377516</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1038/nri2804</idno><idno type="url">https://api.istex.fr/ark:/67375/GT4-SG1QX6JS-6/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001D11</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001D11</idno><idno type="wicri:Area/Istex/Curation">001D11</idno><idno type="wicri:Area/Istex/Checkpoint">000607</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000607</idno><idno type="wicri:doubleKey">1474-1733:2010:Isaacs J:the:changing:face</idno><idno type="wicri:Area/Main/Merge">001665</idno><idno type="wicri:Area/Main/Curation">001662</idno><idno type="wicri:Area/Main/Exploration">001662</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The changing face of rheumatoid arthritis: sustained remission for all?</title><author><name sortKey="Isaacs, John D" sort="Isaacs, John D" uniqKey="Isaacs J" first="John D." last="Isaacs">John D. Isaacs</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cellular Medicine, Musculoskeletal Research Group, Newcastle University Medical School, Framlington Place, Newcastle-upon-Tyne, NE2 4HH</wicri:regionArea><wicri:noRegion>NE2 4HH</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Royaume-Uni</country></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Nature Reviews Immunology</title><idno type="ISSN">1474-1733</idno><idno type="eISSN">1474-1741</idno><imprint><publisher>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</publisher><date when="2010-08">2010-08</date><biblScope unit="vol">10</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="605">605</biblScope><biblScope unit="page" to="611">611</biblScope><date type="Copyright" when="2010">2010</date></imprint><idno type="ISSN">1474-1733</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1474-1733</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">Earlier diagnosis and treatment, plus biological therapies, have transformed the outlook for many patients with rheumatoid arthritis. In the future, new biomarkers for diagnosis, prognosis and therapeutic response will further improve outcomes. Additionally, preclinical diagnosis and tolerogenic therapies could provide sustained remission for some individuals, although ethical and societal challenges must also be addressed before rheumatoid arthritis becomes 'yesterday's disease'.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Isaacs, John D" sort="Isaacs, John D" uniqKey="Isaacs J" first="John D." last="Isaacs">John D. Isaacs</name></noRegion><name sortKey="Isaacs, John D" sort="Isaacs, John D" uniqKey="Isaacs J" first="John D." last="Isaacs">John D. Isaacs</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001662 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001662 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D6B77F81C014C52AFF52CA13D39A16E749377516
|texte= The changing face of rheumatoid arthritis: sustained remission for all?
}}
| This area was generated with Dilib version V0.6.33. |  |